AstraZeneca · 6 hours ago
Clinical Information Science Intern
AstraZeneca is a global biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. They are seeking a Clinical Information Science Intern for a 12-week internship role to assist with data sourcing, preparation, and stakeholder collaboration at their Gaithersburg, MD site.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Identify, ingest, and clean structured and unstructured datasets; document data lineage, assumptions, and quality checks
Use Git, notebooks, and code review to ensure version control, documentation, and repeatable analyses
Gather requirements, validate use cases, and iterate on findings with internal and external partners
Qualification
Required
Sophomore and Junior students majoring in Computer Science, Information Sciences, Engineering, Data science, or a related field
Candidates must have an expected graduation date after August 2026
Programming proficiency in at least one programming language (for e.g. Python, R, SQL): Data manipulation, analysis, and basic modeling using clean, well-documented code
Data visualization experience preferable (Tableau, Power BI, similar): Build intuitive dashboards and charts tailored to stakeholder needs
ETL understanding: Extract, transform, and load data from multiple sources into analytics-ready structures and storage
Basic level of Database knowledge: Work with relational databases and write efficient SQL for data retrieval, joins, and performance-aware queries
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design
US Work Authorization is required at time of application
Ability to report onsite to Gaithersburg, MD site 3 days per week
Preferred
Data visualization experience preferable (Tableau, Power BI, similar): Build intuitive dashboards and charts tailored to stakeholder needs
Machine Learning and AI Familiarity preferred
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Recent News
2026-01-14
Company data provided by crunchbase